These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vitro activity of mecillinam and amoxicillin/clavulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal beta-lactamases. Marre R, Schulz E. Arzneimittelforschung; 1988 Jul; 38(7):863-5. PubMed ID: 3061383 [Abstract] [Full Text] [Related]
4. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium]. Leclercq R, Duval J. Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109 [Abstract] [Full Text] [Related]
5. Comparison of the MicroScan system and the agar dilution assay for Quinupristin/Dalfopristin susceptibility of Enterococcus faecium. Kim YR, Kim SI, Hur JA, Kim YJ, Wie SH, Park YJ, Kang MW. Ann Clin Lab Sci; 2007 Apr; 37(3):260-2. PubMed ID: 17709691 [Abstract] [Full Text] [Related]
6. [Combined antibacterial activity of clavulanic acid with amoxicillin and ampicillin against Gram-negative strains]. Mascellino MT, Prignano G, Lorenzi A, Iegri F, Martorano E, Catania S, Ginanni Corradini S. Boll Ist Sieroter Milan; 1984 Apr; 63(5):447-52. PubMed ID: 6335660 [Abstract] [Full Text] [Related]
7. [Ampicillin-sulbactam activity against respiratory isolates of Haemophilus influenzae]. Cisterna R, Fresnadillo MJ, García-Rodríguez JA, Gobernado M, Martín R, Perea E, Picazo J. Rev Esp Quimioter; 1998 Sep; 11(3):245-50. PubMed ID: 9795311 [Abstract] [Full Text] [Related]
8. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains. Paniagua GL, Monroy E, García O, Vaca S. Rev Latinoam Microbiol; 1998 Sep; 40(3-4):128-34. PubMed ID: 10932741 [Abstract] [Full Text] [Related]
9. [Errors of the agar diffusion method to predict Escherichia coli's susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid]. Villar HE, Jugo MB, Fernández-Lausi A, Farinati AE. Enferm Infecc Microbiol Clin; 1996 May; 14(5):308-10. PubMed ID: 8744371 [Abstract] [Full Text] [Related]
10. [Pattern of antimicrobial susceptibility of enterococci strains]. Hoyos A, Gutiérrez J, Piédrola G. Rev Med Chil; 1995 Apr; 123(4):473-8. PubMed ID: 8525192 [Abstract] [Full Text] [Related]
11. [Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital]. Bémer-Melchior P, Gilly L, Jugroot-Klotz K, Brun T, Névot P, Paul G. Pathol Biol (Paris); 1995 Nov; 43(9):760-5. PubMed ID: 8746097 [Abstract] [Full Text] [Related]
12. [Appearance of Escherichia coli strain with high production of cephalosporinase during treatment with an amoxicillin and clavulanic acid combination]. Aubert G, Peyle V, Dumont N, el Fassi M, Dorche G. Ann Biol Clin (Paris); 1990 Nov; 48(7):449-54. PubMed ID: 2278408 [Abstract] [Full Text] [Related]
13. [Susceptibility of Enterococcus genus to new antimicrobial agents]. Sánchez-Molina MI, Martín D, Valladares C, Gastañares MJ, Torres C, Borque L. Rev Esp Quimioter; 2004 Jun; 17(2):184-8. PubMed ID: 15470513 [Abstract] [Full Text] [Related]
14. [Resistance of Escherichia coli isolated from the urinary tract to amoxicillin-clavulanic acid and other antibiotics]. Ferjani A, Marzouk M, Ben Moussa F, Boukadida J. Med Mal Infect; 2010 Mar; 40(3):161-4. PubMed ID: 19616395 [Abstract] [Full Text] [Related]
15. Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different {beta}-lactams: an in vitro pharmacodynamic approach. González N, Aguilar L, Alou L, Giménez MJ, Sevillano D, Torrico M, Cafini F, Coronel P, Prieto J. J Antimicrob Chemother; 2009 Jun; 63(6):1215-22. PubMed ID: 19307171 [Abstract] [Full Text] [Related]
16. [In vitro and in vivo activity of a combination of clavulanic acid and amoxicillin against Klebsiella pneumoniae producing extended broad-spectrum betalactamase (CTX-1, SHV-3, SHV-4)]. Migueres ML, Ronco E, Guenounou M, Philippon A. Pathol Biol (Paris); 1989 May; 37(5):397-401. PubMed ID: 2674869 [Abstract] [Full Text] [Related]
17. [Sensitivity to clavulanic acid of Escherichia coli isolated at the Henri Mondor hospital in 1986 according to phenotypes of beta-lactam antibiotic resistance]. Soussy CJ, Le Van Thoi J, Duval J. Pathol Biol (Paris); 1988 May; 36(5):442-5. PubMed ID: 3043340 [Abstract] [Full Text] [Related]
18. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000. Koeth LM, Jacobs MR, Good CE, Bajaksouzian S, Windau A, Jakielaszek C, Saunders KA. Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258 [Abstract] [Full Text] [Related]
19. [A comparison of the in vitro susceptibility of three bacteria to beta-lactamase inhibitors and to ampicillin and cefazolin]. Acar N, Diri MC, Türkyilmaz FR. Mikrobiyol Bul; 1987 Oct; 21(4):284-8. PubMed ID: 3332705 [Abstract] [Full Text] [Related]
20. [Detection of resistance to the amoxicillin-clavulamic acid combination in Salmonella and Shigella]. Miró E, Mirelis B, Navarro F, Prats G. Enferm Infecc Microbiol Clin; 1996 Jan; 14(1):31-3. PubMed ID: 8714185 [Abstract] [Full Text] [Related] Page: [Next] [New Search]